• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝标记的胃泌素释放肽类似物在表达胃泌素释放肽受体的肿瘤中的定位:肽长度和中性内肽酶抑制对生物学反应的影响

Localization of Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.

作者信息

Kaloudi Aikaterini, Lymperis Emmanouil, Kanellopoulos Panagiotis, Waser Beatrice, de Jong Marion, Krenning Eric P, Reubi Jean Claude, Nock Berthold A, Maina Theodosia

机构信息

Molecular Radiopharmacy, INRASTES, NCSR "Demokritos", 15310 Athens, Greece.

Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland.

出版信息

Pharmaceuticals (Basel). 2019 Mar 20;12(1):42. doi: 10.3390/ph12010042.

DOI:10.3390/ph12010042
PMID:30897789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6469168/
Abstract

The overexpression of gastrin-releasing peptide receptors (GRPRs) in frequently occurring human tumors has provided the opportunity to use bombesin (BBN) analogs as radionuclide carriers to cancer sites for diagnostic and therapeutic purposes. We have been alternatively exploring human GRP motifs of higher GRPR selectivity compared to frog BBN sequences aiming to improve pharmacokinetic profiles. In the present study, we compared two differently truncated human endogenous GRP motifs: GRP(14⁻27) and GRP(18⁻27). An acyclic tetraamine was coupled at the N-terminus to allow for stable binding of the SPECT radionuclide Tc. Their biological profiles were compared in PC-3 cells and in mice without or with coinjection of phosphoramidon (PA) to induce transient neprilysin (NEP) inhibition in vivo. The two Tc-N₄-GRP(14/18⁻27) radioligands displayed similar biological behavior in mice. Coinjection of PA exerted a profound effect on in vivo stability and translated into notably improved radiolabel localization in PC-3 experimental tumors. Hence, this study has shown that promising Tc-radiotracers for SPECT imaging may indeed derive from human GRP sequences. Radiotracer bioavailability was found to be of major significance. It could be improved during in situ NEP inhibition resulting in drastically enhanced uptake in GRPR-expressing lesions.

摘要

胃泌素释放肽受体(GRPRs)在常见人类肿瘤中的过表达为利用蛙皮素(BBN)类似物作为放射性核素载体至癌症部位用于诊断和治疗目的提供了契机。我们一直在探索与蛙BBN序列相比具有更高GRPR选择性的人GRP基序,旨在改善药代动力学特征。在本研究中,我们比较了两种不同截短的人内源性GRP基序:GRP(14⁻27)和GRP(18⁻27)。在N端偶联一个无环四胺以允许单光子发射计算机断层扫描(SPECT)放射性核素锝(Tc)的稳定结合。在PC-3细胞以及在未注射或共注射磷酰胺素(PA)以在体内诱导短暂的中性内肽酶(NEP)抑制的小鼠中比较它们的生物学特性。两种Tc-N₄-GRP(14/18⁻27)放射性配体在小鼠中表现出相似的生物学行为。共注射PA对体内稳定性产生了深远影响,并转化为PC-3实验肿瘤中显著改善的放射性标记定位。因此,本研究表明,用于SPECT成像的有前景的Tc放射性示踪剂确实可能源自人GRP序列。发现放射性示踪剂的生物利用度至关重要。在原位NEP抑制过程中其可得到改善,从而导致在表达GRPR的病变中摄取大幅增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/74bfd30749ab/pharmaceuticals-12-00042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/ae73cc31846c/pharmaceuticals-12-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/91505f5c19c5/pharmaceuticals-12-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/83ac1fa85cee/pharmaceuticals-12-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/74bfd30749ab/pharmaceuticals-12-00042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/ae73cc31846c/pharmaceuticals-12-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/91505f5c19c5/pharmaceuticals-12-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/83ac1fa85cee/pharmaceuticals-12-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/6469168/74bfd30749ab/pharmaceuticals-12-00042-g004.jpg

相似文献

1
Localization of Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.锝标记的胃泌素释放肽类似物在表达胃泌素释放肽受体的肿瘤中的定位:肽长度和中性内肽酶抑制对生物学反应的影响
Pharmaceuticals (Basel). 2019 Mar 20;12(1):42. doi: 10.3390/ph12010042.
2
[Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.[Tc]Tc-DB1 模拟不同长度的 PEG 间隔物:GRPR 阳性模型中的临床前比较。
Molecules. 2020 Jul 28;25(15):3418. doi: 10.3390/molecules25153418.
3
99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.基于人源 GRP(18-27)的 99mTc 放射性示踪剂:合成与比较评价。
J Nucl Med. 2013 Oct;54(10):1797-803. doi: 10.2967/jnumed.112.118695. Epub 2013 Sep 5.
4
Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.酰胺-三唑转换与体内抑制中性内肽酶方法以促进放射性肽靶向胃泌素释放肽受体阳性肿瘤
Nucl Med Biol. 2017 Sep;52:57-62. doi: 10.1016/j.nucmedbio.2017.06.001. Epub 2017 Jun 10.
5
(99m)Tc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice.不同肽链长度的(99m)Tc标记胃泌素:中性内肽酶/血管紧张素转换酶抑制对小鼠稳定性和肿瘤摄取的不同影响
Nucl Med Biol. 2016 Jun;43(6):347-54. doi: 10.1016/j.nucmedbio.2016.03.003. Epub 2016 Mar 19.
6
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice.体内酶抑制作用改善了[177Lu]DOTA-GRP(13 - 27)在小鼠GRPR阳性肿瘤中的靶向性。
Cancer Biother Radiopharm. 2014 Nov;29(9):359-67. doi: 10.1089/cbr.2014.1706. Epub 2014 Oct 6.
7
[(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.[(99m)Tc]德美辛 C,一种基于人胃泌素释放肽(18-27)的放射性配体:在胃泌素释放肽受体表达模型中的合成和临床前评价。
J Med Chem. 2012 Oct 11;55(19):8364-74. doi: 10.1021/jm300741f. Epub 2012 Sep 26.
8
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [Tc]Tc-DB4 and [In]In-SG4 in Mice Treated with Entresto.向临床转化迈进了一步:在接受恩格列净治疗的小鼠中,[锝]Tc-DB4和[铟]In-SG4的肿瘤靶向性增强
Pharmaceutics. 2020 Nov 26;12(12):1145. doi: 10.3390/pharmaceutics12121145.
9
Comparative evaluation of the new GRPR-antagonist In-SB9 and In-AMBA in prostate cancer models: Implications of in vivo stability.新型胃泌素释放肽受体拮抗剂In-SB9和In-AMBA在前列腺癌模型中的比较评估:体内稳定性的影响
J Labelled Comp Radiopharm. 2019 Aug;62(10):646-655. doi: 10.1002/jlcr.3733. Epub 2019 Jun 13.
10
Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison.基于截短型人胃泌素释放肽序列的新型 111In-放射性配体用于肿瘤诊断:合成与临床前比较。
J Med Chem. 2013 Nov 14;56(21):8579-87. doi: 10.1021/jm4010237. Epub 2013 Oct 23.

引用本文的文献

1
Optimization of the Pharmacokinetic Profile of [Tc]Tc-N-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence.通过修饰药效基团Gln-Trp序列优化[锝(Tc)]Tc-N-蛙皮素衍生物的药代动力学特征
Pharmaceuticals (Basel). 2022 Sep 10;15(9):1133. doi: 10.3390/ph15091133.
2
Radiolabeled Bombesin Analogs.放射性标记的蛙皮素类似物。
Cancers (Basel). 2021 Nov 17;13(22):5766. doi: 10.3390/cancers13225766.
3
Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga]Ga-NOTA-PEG-RM26.

本文引用的文献

1
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.放射性核素依赖的放射性标记胃泌素释放肽受体拮抗剂 SB3 在癌症治疗学中的生物学特征:由肾素定义的代谢和生物分布模式。
Bioconjug Chem. 2018 May 16;29(5):1774-1784. doi: 10.1021/acs.bioconjchem.8b00225. Epub 2018 Apr 30.
2
Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.酰胺-三唑转换与体内抑制中性内肽酶方法以促进放射性肽靶向胃泌素释放肽受体阳性肿瘤
Nucl Med Biol. 2017 Sep;52:57-62. doi: 10.1016/j.nucmedbio.2017.06.001. Epub 2017 Jun 10.
3
前列腺癌中 GRPR 表达的 Ga-PET 成像:[Ga]Ga-NOTA-PEG-RM26 的制备和特性研究。
Sci Rep. 2021 Feb 11;11(1):3631. doi: 10.1038/s41598-021-82995-7.
4
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [Tc]Tc-DB4 and [In]In-SG4 in Mice Treated with Entresto.向临床转化迈进了一步:在接受恩格列净治疗的小鼠中,[锝]Tc-DB4和[铟]In-SG4的肿瘤靶向性增强
Pharmaceutics. 2020 Nov 26;12(12):1145. doi: 10.3390/pharmaceutics12121145.
5
[Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.[Tc]Tc-DB1 模拟不同长度的 PEG 间隔物:GRPR 阳性模型中的临床前比较。
Molecules. 2020 Jul 28;25(15):3418. doi: 10.3390/molecules25153418.
Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.
胃泌素释放肽受体放射性拮抗剂在肿瘤学中的诊疗前景
PET Clin. 2017 Jul;12(3):297-309. doi: 10.1016/j.cpet.2017.02.007. Epub 2017 Apr 3.
4
From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer.从实验台到病床:新型胃泌素释放肽受体导向放射性配体及其在前列腺癌中的应用
PET Clin. 2017 Apr;12(2):205-217. doi: 10.1016/j.cpet.2016.12.002. Epub 2017 Jan 31.
5
Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.蛙皮素相关肽/受体及其在癌症成像、靶向和治疗中的潜在治疗作用。
Expert Opin Ther Targets. 2016 Sep;20(9):1055-73. doi: 10.1517/14728222.2016.1164694. Epub 2016 Mar 28.
6
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.胃泌素释放肽受体拮抗剂的体内稳定化在临床前研究中增强了前列腺癌的PET成像和放射性核素治疗。
Theranostics. 2016 Jan 1;6(1):104-17. doi: 10.7150/thno.13580. eCollection 2016.
7
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice.体内酶抑制作用改善了[177Lu]DOTA-GRP(13 - 27)在小鼠GRPR阳性肿瘤中的靶向性。
Cancer Biother Radiopharm. 2014 Nov;29(9):359-67. doi: 10.1089/cbr.2014.1706. Epub 2014 Oct 6.
8
GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study.使用[(99m)Tc]地莫贝辛4对前列腺癌进行胃泌素释放肽受体成像:一项人体首例研究。
Mol Imaging Biol. 2014 Dec;16(6):888-95. doi: 10.1007/s11307-014-0754-z.
9
Gastrin-releasing peptide receptor expression in lung cancer.肺癌中胃泌素释放肽受体的表达。
Arch Pathol Lab Med. 2014 Jan;138(1):98-104. doi: 10.5858/arpa.2012-0679-OA.
10
"To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.“为服务和保护”:酶抑制剂作为放射性肽配体促进肿瘤靶向。
J Nucl Med. 2014 Jan;55(1):121-7. doi: 10.2967/jnumed.113.129411. Epub 2013 Nov 28.